MarketInOut Stock Screener Log In | Sign Up
 

Penumbra Inc

NYSE • Healthcare • Medical Devices • Quote as of 10/23/2026
Penumbra Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization12,800 mln
Float38.26 mln
Earnings Date11/04/2026

EPS

4.07
Stretched

P / E

79.70
Speculative

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.72
Likely reliable

Relative Strength

68 / 100
Outperforming

Debt / Equity

0.14
Very low leverage

Business Description

Penumbra Inc. is a California-based medical device company founded in 2004 that develops and sells a broad range of tools for treating complex vascular and neurovascular conditions. Its products help physicians remove blood clots, restore blood flow, and treat aneurysms in both the brain and the body, with offerings sold across the United States and in international markets. The company reaches its customers through a combination of its own sales teams and third-party distributors.

Key Fundamentals

EPS4.07
P/E79.70
ROE11.33
RPS38.36
ROIC12.42
ROA8.81
Interest Cover144
EBITDA, mln222
EV / EBITDA54.77
EV / EBIT59.35
Revenue, mln1,505
EV / Revenue8.09

Quote Details

Last 324.39
Change -0.57 (-0.18%)
Open 324.96
Volume 357,894
Turnover 116,097,240
Average Volume 322,651

Financial Ratios

Pre-Tax Profit Margin14
Leverage Ratio1.29
Current Ratio5.75
Price / Book8.21
Price / Tangible Book9.25
Price / Cash Flow45.99
Price / Free Cash Flow58.28
Debt / Equity0.14
Price / Sales8.36
PEG Ratio3.65

Financial Strength

Altman Z-Score18.97
Piotroski F-Score 6 / 9
Beneish M-Score-2.72
Price to Intrinsic Value5.95
Price to Graham Number5.67
Shiller PE Ratio282
Short Ratio6.03
Short % of Float6.56

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.1% 70 / 100   
1 Month 1.46% 68 / 100   
2 Months 2.01% 69 / 100   
6 Months -1.67% 42 / 100   
1 Year 28.71% 85 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog